prednisone treatment

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire Dijon

Conditions

Giant Cell ArteritisPatients Relapsing Refractory Giant Cell Arteritis

Phase 2

Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis

CompletedNCT03711448

Centre Hospitalier Universitaire DijonPatients Relapsing Refractory Giant Cell Arteritis

Start: 2019-01-07End: 2024-09-11Updated: 2024-10-04

Phase 3

MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial

Active, not recruitingNCT03892785

Centre Hospitalier Universitaire DijonGiant Cell Arteritis

Start: 2020-01-27End: 2027-01-01Updated: 2026-04-24